COVID-19: Vaccines and Therapeutics

The AHA welcomes President Biden and his Administration joining us in sounding the alarm over the national workforce crisis facing America’s hospitals and health systems, along with the need to respond to the impact of the current surge and the urgent need to get everyone fully vaccinated and…
Researchers at Charleston, S.C.-based MUSC, who are studying COVID-19 variants, warn of a new surge in cases and urge people to get vaccinated or “boosted.”
For nearly two years, our nation’s physicians, nurses and other health care professionals have seen firsthand the tragic impact of COVID-19 on the patients and colleagues they have lost as well as those suffering from the virus’ long-term effects and the families and loved ones left behind. 
Clinicians at Sanford Health in South Dakota are connecting with their community via digital platforms to address concerns about the COVID-19 omicron variant.
The AHA has released new resources that hospitals and health systems can use to encourage communities to stay healthy and protect themselves against the flu and COVID-19.
Pfizer said it has submitted a supplemental biologics license application for its COVID-19 vaccine, asking that the Food and Drug Administration expand approval to include individuals age 12 to 15.
The Centers for Disease Control and Prevention endorsed updated recommendations expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine, as proposed by the agency’s Advisory Committee on Immunization Practices. 
The AHA, American Medical Association and American Nurses Association shared the following statement with the media calling for widespread vaccinations and booster shots during the holiday season as the omicron variant spreads. 
The federal government asked the U.S. Supreme Court to stay the Missouri and Louisiana district court preliminary injunctions that have put the Centers for Medicare & Medicaid Services vaccine mandate on hold in 24 states.
The U.S. COVID-19 Vaccination Program has helped avert an estimated 35.9 million infections, 10.3 million hospitalizations and 1.1 million deaths as of Nov. 30, according to an analysis released by the Commonwealth Fund.